RPN4 Antibody

What is RPN4 and what are its biological functions?

RPN4 is a transcription factor that primarily regulates proteasome biogenesis. In yeast systems, RPN4 functions as a key regulator of proteasome gene expression, while in humans, the corresponding protein is known as proteasome 26S subunit, non-ATPase 9 (PSMD9), encoded by the PSMD9 gene . The protein acts as a chaperone during the assembly of the 26S proteasome, specifically assisting with the formation of the base subcomplex of the PA700/19S regulatory complex (RC) .

RPN4 has been identified as a critical factor that cooperates with the Unfolded Protein Response (UPR) during endoplasmic reticulum (ER) stress . Its abundance increases during ER stress, suggesting that enhanced proteasome biogenesis is a key mechanism for promoting ER stress resistance . Additionally, recent research has demonstrated RPN4's role in activating its own transcription and regulating fluconazole resistance in Candida auris through the activation of efflux pump gene expression .

What are the structural characteristics of RPN4 protein?

The human homolog of RPN4 (PSMD9/p27) is canonically 223 amino acids in length with a molecular mass of approximately 24.7 kilodaltons . It belongs to the Proteasome subunit p27 protein family and is expressed in all tissues tested, with particularly high expression in the liver and kidney . The protein is also known by several alias names including p27 and 26S proteasome non-ATPase regulatory subunit 9 .

In yeast species, RPN4 functions as a transcription factor that binds to promoters of proteasome subunit genes, thus controlling proteasome biogenesis. The RPN4 regulon encompasses many genes beyond those encoding proteasome subunits, including those involved in oxidative stress responses and endoplasmic reticulum-associated protein degradation (ERAD) .

What types of RPN4 antibodies are available for research?

Several types of RPN4 antibodies are available for research purposes:

These antibodies are primarily used for Western Blot (WB) applications, although some are also suitable for Enzyme-Linked Immunosorbent Assay (ELISA), Immunofluorescence (IF), and Immunohistochemistry (IHC) . When selecting an RPN4 antibody, researchers should consider species specificity, as antibodies targeting human PSMD9 versus yeast RPN4 are not typically cross-reactive due to sequence differences.

How does RPN4 cooperate with the Unfolded Protein Response (UPR)?

RPN4 works in parallel with, rather than downstream of, the Unfolded Protein Response (UPR) to enhance cellular resistance to ER stress . Research has shown that RPN4 is not controlled by Hac1 (a key UPR transcription factor) and is not a UPR target gene . The transcriptional programs activated by the UPR and RPN4 are largely distinct but functionally complementary, representing two cooperating modules of the cellular stress response .

Studies manipulating RPN4 levels in wild-type and Δhac1 (UPR-deficient) cells demonstrated that:

• Overexpression of RPN4 in wild-type cells increased resistance to ER stressors like tunicamycin and misfolded proteins

• Deletion of RPN4 sensitized cells to ER stress

• RPN4 overexpression provided protection in UPR-deficient (Δhac1) cells

• Double mutants (Δhac1 Δrpn4) showed synthetic sickness, growing poorly even without stress conditions

These findings reveal that RPN4 and the UPR are functionally linked, with RPN4 activity becoming limiting for cell proliferation during ER stress, even when the UPR is intact .

What is the regulatory mechanism of RPN4 during ER stress?

RPN4 abundance is regulated through both transcriptional and post-transcriptional mechanisms during ER stress:

• Short-term ER stress (up to 60 minutes): In wild-type cells, tunicamycin treatment increases RPN4 protein levels without affecting RPN4 mRNA levels, suggesting regulation primarily through reduced protein degradation .

• UPR-deficient cells: In Δhac1 cells, tunicamycin treatment increases both RPN4 protein abundance and mRNA levels more significantly than in wild-type cells, indicating enhanced transcription contributes to RPN4 accumulation .

• Prolonged ER stress: Extended treatment with higher concentrations of tunicamycin (5 μg/ml) elevates RPN4 mRNA levels even in wild-type cells, leading to increased abundance of proteasome subunits and assembly chaperones .

These findings demonstrate that during ER stress, cells augment the UPR by enhancing RPN4 activity and promoting proteasome biogenesis, providing a coordinated stress response mechanism .

What is the role of RPN4 in antifungal drug resistance?

RPN4 plays a critical role in antifungal drug resistance, particularly in pathogenic fungi like Candida auris. Recent research has identified RPN4 as a key transcription factor that regulates fluconazole resistance through the activation of efflux pump genes .

Studies examining the impact of RPN4 on drug resistance found that:

• Deletion of genes encoding negative regulators of RPN4 (UBR2 and MUB1) results in increased RPN4 levels and enhanced fluconazole resistance .

• RPN4 positively regulates the expression of multiple efflux genes, including SNQ21, SNQ22, MDR1, and CDR1, which are known to play important roles in drug resistance in various fungal pathogens .

• Cells with elevated RPN4 levels (ubr2Δ and mub1Δ mutants) show increased export of drug-like compounds (R6G and NR), and deletion of RPN4 in these mutants reduces their efflux activities to wild-type levels .

These findings establish an RPN4-efflux pump axis as a critical regulatory mechanism for antifungal drug resistance in C. auris, providing insights into potential therapeutic targets for combating resistant fungal infections .

What are the optimal experimental conditions for using RPN4 antibodies in Western Blot?

When using RPN4 antibodies for Western Blot analysis, researchers should consider the following methodological details:

• Antibody selection: Choose an antibody specific to your species of interest (human PSMD9 vs. yeast RPN4) .

• Sample preparation: When studying stress responses, carefully time your sample collection. RPN4 protein levels increase rapidly during stress conditions, with significant changes observable within 15-60 minutes of stress induction .

• Controls: Include both positive controls (cells overexpressing RPN4) and negative controls (Δrpn4 cells) to validate antibody specificity .

• Quantification: For accurate quantification of RPN4 abundance changes during stress responses, normalize to an appropriate loading control and present data relative to basal/untreated conditions .

• Detection of post-translational modifications: Since RPN4 regulation often involves protein stability, consider using proteasome inhibitors in parallel samples to distinguish between transcriptional and post-transcriptional regulation mechanisms .

Based on published methodologies, exposure to stressors such as tunicamycin at 2-5 μg/ml can induce detectable changes in RPN4 protein levels within 15 minutes, with more pronounced changes after 60 minutes of treatment .

How can RPN4 activity be measured in experimental systems?

Measuring RPN4 activity in experimental systems can be accomplished through several approaches:

• Reporter constructs: RPN4 activity can be measured using reporter systems where fluorescent proteins (e.g., mNeonGreen) are placed under the control of an RPN4-responsive promoter . By normalizing to a constitutively expressed control (e.g., BFP under GPD promoter), researchers can quantify RPN4 transcriptional activity in living cells .

• Quantitative PCR: Measure the expression levels of known RPN4 target genes, such as proteasome subunit genes or efflux pumps (in fungi) . This approach provides an indirect measure of RPN4 activity.

• Protein abundance analysis: Quantify the abundance of proteasome subunits and assembly chaperones, which increase in response to RPN4 activation .

For reporter-based measurements, researchers typically:

• Grow cells to mid-log phase

• Measure baseline fluorescence

• Apply stress conditions (e.g., tunicamycin treatment)

• Take time-course measurements of fluorescence signals

• Calculate fluorescence ratios between the RPN4 reporter and a constitutive control

• Normalize treated samples to untreated controls

This approach allows for temporal monitoring of RPN4 activation in response to various stressors.

What experimental approaches can be used to study RPN4's role in stress responses?

To investigate RPN4's role in cellular stress responses, researchers can employ several experimental strategies:

• Genetic manipulation:

  • RPN4 overexpression using inducible promoters (e.g., GAL promoter with estradiol induction)

  • RPN4 deletion (Δrpn4) to assess loss-of-function effects

  • Combination with other mutations (e.g., Δhac1 Δrpn4) to study genetic interactions

• Stress reporters:

  • Monitor multiple stress response pathways simultaneously using pathway-specific reporters:

    • HAC1 splicing reporter for UPR activation

    • Heat shock element (HSE) reporter for Hsf1-dependent heat shock response

    • HSP12 reporter for Msn2/4-dependent general stress response

• Proteasome activity assays:

  • Measure proteasome functionality in relation to RPN4 levels

  • Assess degradation rates of model substrates

• Drug resistance assays:

  • Evaluate sensitivity to ER stressors (e.g., tunicamycin, DTT)

  • Test resistance to antifungal drugs (e.g., fluconazole)

  • Measure efflux activity using fluorescent substrates like R6G and NR

• Transcriptome analysis:

  • Compare gene expression profiles between wild-type, RPN4-overexpressing, and Δrpn4 cells under normal and stress conditions

  • Identify the complete RPN4 regulon in your system of interest

These approaches, used individually or in combination, can provide comprehensive insights into RPN4's functions in different stress response contexts.

What are the current gaps in our understanding of RPN4 function?

Despite significant advances in understanding RPN4 biology, several important questions remain:

• The precise mechanism by which RPN4 recognizes and activates its target genes in different cellular contexts requires further characterization.

• While RPN4's role in proteasome biogenesis is well-established, the relative contributions of different components of the RPN4 regulon to stress resistance remain to be delineated .

• The evolutionary conservation of RPN4 functions between yeast models and mammalian systems, where PSMD9 may serve similar roles, needs further investigation.

• The potential of RPN4 as a therapeutic target for addressing drug resistance in pathogenic fungi requires additional exploration .

What emerging research directions might advance our understanding of RPN4 biology?

Future research on RPN4 could profitably focus on:

• Structural studies of RPN4/PSMD9 to better understand its function as both a transcription factor and a proteasome assembly chaperone.

• Systems-level analyses to identify all genes regulated by RPN4 across different stress conditions and model organisms.

• Development of small molecule modulators of RPN4 activity that could serve as research tools or potential therapeutic agents.

• Investigation of RPN4's potential role in human disease contexts, particularly those involving proteasome dysfunction or stress response pathways.

• Exploration of the RPN4-efflux pump axis as a target for combating antifungal resistance in clinical settings .